BioPhotas Inc. Celebrates 15 Years with Innovative Light Therapy Launch

Celebrating 15 Years of Innovation: BioPhotas Inc. Launches Celluma MYSTIQUE

BioPhotas Inc., a pioneering force in therapeutic LED light therapy devices, recently marked a significant milestone—its 15th anniversary. To commemorate this occasion, the company has unveiled an innovative product that promises to revolutionize the light therapy market: the Celluma MYSTIQUE. This new device is a game changer, designed to enhance skin health while simultaneously treating hair loss, all from one comfortable, bespoke device.

Unveiling the Celluma MYSTIQUE

The Celluma MYSTIQUE stands out as the first FDA-cleared LED mask that effectively treats acne, facial wrinkles, and hair loss on the scalp. This remarkable device is anticipated to receive regulatory approval for sales across the United Kingdom, European Union, Canada, and Mexico in the upcoming weeks, following its strong debut in the U.S. market.

In a live event hosted in honor of their anniversary, Patrick Johnson, the Chairman and Chief Innovation Officer of BioPhotas, discussed the development of the MYSTIQUE. During the Fireside Chat with Barry Eichner, a noted expert in the beauty industry, they explored the rapid growth of the mask segment within the light therapy domain post-pandemic. Johnson emphasized the belief that many existing LED masks mimic the appearance of professional-grade technology without delivering actual therapeutic effectiveness. He said, “Our users have been asking us for years, 'When is Celluma going to make an LED mask?' Our answer has always been 'When we can make a Celluma mask.'” With the introduction of the MYSTIQUE, that promise is fulfilled.

Proven Technology and Performance

The MYSTIQUE's efficacy is rooted in the advanced control electronics that are a hallmark of the Celluma SERIES. It offers five distinct treatment protocols and the unique ability to administer treatments to both the face and scalp simultaneously—a feat unmatched by other devices on the market today. This innovative mask also incorporates a patented, flexible design that adapts to the user's facial and scalp contours, ensuring both comfort and accurate light energy delivery.

Curtis Cluff, the Chief Executive Officer of BioPhotas, described the MYSTIQUE as a major leap forward not only for their product line but for the industry at large. He stated, “For 15 years, we've led the evolution of low-level light therapy through clinically validated, professional-grade solutions. With MYSTIQUE, we've brought that same standard of performance into an entirely new form factor, without compromise.” Users can look forward to significant improvements after just four weeks of consistent use, three times a week.

BioPhotas is committed to quality, with the MYSTIQUE designed and manufactured in the United States. It will be available for pre-orders at a special introductory price of $795, with shipping expected to commence by the end of May 2026. Following the initial launch, the retail price will rise to $895.

For those eager to discover the future of light therapy, the Celluma MYSTIQUE exemplifies the very best in technology and innovation available today. Interested consumers can learn more and place their orders by visiting Celluma.com.

Looking Ahead

As BioPhotas celebrates 15 years of commitment to innovation and excellence in light therapy, the introduction of the Celluma MYSTIQUE represents a promising stride towards enhancing health and wellness solutions for a wide audience. This latest addition solidifies BioPhotas's position at the forefront of the industry, as they continue to create safe, effective, and clinically proven light therapy options that consumers can trust.

Stay tuned for more updates on their advancements and the evolving landscape of LED light therapy.